An interventional study of Manual Diaphragm Release and control group in Respiratory System Abnormalities, sponsored by Maged Basha. Completed at 1 site in Saudi Arabia. Open to female participants aged 35 Years to 45 Years. Per ClinicalTrials.gov, last updated 2023-04-06.
Sponsored by Maged Basha · Not applicable, Interventional, and Treatment
This study intended to examine the effect of manual diaphragm release on pulmonary function, chest wall mobility, and functional ability in female occupational cleaners with respiratory hazards.
Cleaning chores have been linked to exposure to various chemical agents that have the potential to cause harmful effects on both the respiratory system and cardiovascular markers, many cleaning products and disinfectants contain ingredients that can act as airway irritants. One of the physical therapy procedures that is used to manage chest disorders is manual diaphragm release which aims to lengthen the diaphragm musculature whereas encouraging better and more proficient contraction.
Maged Basha is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
received 3sessions/ week for 12 consecutive weeks.
Other: Manual Diaphragm Release
received 3sessions/ week for 12 consecutive weeks.
Other: control group
The participant was supine, with his or her limbs relaxed. With the therapist's forearms aligned toward the participant's shoulders, the therapist gradually increased the depth of contact inside the costal margin during the subsequent respiratory cycles.
Also known as: inspiratory resistance
Respiratory re-training was given to participants in control group in form of slow and deep diaphragmatic breathing, exhalation through the nose with pursed lips (the participants were trained to emphasis on expiratory pressure against pursed lips), Breathing control and breathing-hold exercises, and Relaxation techniques:
Also known as: Respiratory re-training
Serum IgE
The Organon Teknika Microwell system (Organon Teknika Corp, Boxtel, the Netherlands) and an enzyme-linked immunosorbent test kits, were utilized to assess total serum IgE (IU/mL) at 450 nm.
Time frame: at first week
Serum IgE
The Organon Teknika Microwell system (Organon Teknika Corp, Boxtel, the Netherlands) and an enzyme-linked immunosorbent test kits, were utilized to assess total serum IgE (IU/mL) at 450 nm.
Time frame: after 12 weeks
Forced vital capacity
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Time frame: at first week
Forced vital capacity
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Time frame: after 12 weeks
Forced expiratory volume in one second
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Time frame: at first week
Forced expiratory volume in one second
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Time frame: after 12 weeks
pulmonary expiratory flow
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Time frame: at first week
pulmonary expiratory flow
measured using a portable MicroLab spirometer (Vyaire Medical, Mettawa, Illinois) in accordance with current lung function testing standards
Time frame: after 12 weeks
Chest wall mobility
measured using tape measurement with maximum inspiration and expiration and the difference between them has been recorded in (cm).
Time frame: at first week
Chest wall mobility
measured using tape measurement with maximum inspiration and expiration and the difference between them has been recorded in (cm).
Time frame: after 12 weeks
Functional performance
Assessed using the 6-minute walk test
Time frame: at first week
Functional performance
Assessed using the 6-minute walk test
Time frame: after 12 weeks
Plan to share: Yes — The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Supporting information: Study protocol
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory System Abnormalities